Back to search

Article

Clinical Outcomes after Percutaneous Coronary Intervention Over Time on the Basis of CYP2C19 Polymorphisms: Evidence from a Chinese Cohort

2021-05-28

Abstract excerpt

<title>Abstract</title> <p><bold>Purpose：</bold>To investigate the association between CYP2C19 gene polymorphism and the risk of ischemic and bleeding complications in the different period after percutaneous coronary intervention (PCI) among patients who received clopidogrel.<bold>Methods：</bold>Between October 2015 and January 2017, CYP2C19 genotyped patients who were treated clopidogrel after PCI were enrolled...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e85a6ec0-7ded-539f-b691-1887efb7e412
DOI
10.21203/rs.3.rs-503780/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical Outcomes after Percutaneous Coronary Intervention Over Time on the Basis of CYP2C19 Polymorphisms: Evidence from a Chinese CohortDOI 10.21203/rs.3.rs-503780/v1
Clinical Outcomes After Percutaneous Coronary Intervention Over Time on the Basis of CYP2C19 Polymorphisms.Semantic proximity
CYP2C19 genotype has a greater effect on adverse cardiovascular outcomes following percutaneous coronary intervention and in Asian populations treated with clopidogrel: a meta-analysis.Semantic proximity
Effects of the CYP2C19 LoF allele on major adverse cardiovascular events associated with clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis.Semantic proximity
CYP2C19 and effect of clopidogrel for secondary prevention of major ischemic events: systematic review and meta-analysisSemantic proximity
<i>CYP2C19</i>Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention (PCI) in the Million Veterans ProgramSemantic proximity
CYP2C19 genotype and adverse cardiovascular outcomes after stent implantation in clopidogrel-treated Asian populations: A systematic review and meta-analysis.Semantic proximity
Clopidogrel versus Ticagrelor in CYP2C19 Loss-of-Function Allele Noncarriers: A Real-World Study in China.Semantic proximity
[Impact of cytochrome P450 2C19 polymorphisms on outcome of cardiovascular events in clopidogrel-treated Chinese patients after percutaneous coronary intervention].Semantic proximity
Variant recurrent risk among stroke patients with different CYP2C19 phenotypes and treated with clopidogrel.Semantic proximity
Effects of individualized antiplatelet therapy based on CYP2C19 genotype and platelet function on the prognosis of patients after PCI.Semantic proximity
Clinical Impact of CYP2C19 Genotype on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention.Semantic proximity
CYP2C19 phenotype, stent thrombosis, myocardial infarction, and mortality in patients with coronary stent placement in a Chinese population.Semantic proximity
Select a neighboring publication to make it the new centre.